Cite
The impact of clinical genome sequencing in a global population with suspected rare genetic disease.
MLA
Thorpe, Erin, et al. “The Impact of Clinical Genome Sequencing in a Global Population with Suspected Rare Genetic Disease.” American Journal of Human Genetics, vol. 111, no. 7, July 2024, pp. 1271–81. EBSCOhost, https://doi.org/10.1016/j.ajhg.2024.05.006.
APA
Thorpe, E., Williams, T., Shaw, C., Chekalin, E., Ortega, J., Robinson, K., Button, J., Jones, M. C., Campo, M. D., Basel, D., McCarrier, J., Keppen, L. D., Royer, E., Foster-Bonds, R., Duenas-Roque, M. M., Urraca, N., Bosfield, K., Brown, C. W., Lydigsen, H., … Taft, R. J. (2024). The impact of clinical genome sequencing in a global population with suspected rare genetic disease. American Journal of Human Genetics, 111(7), 1271–1281. https://doi.org/10.1016/j.ajhg.2024.05.006
Chicago
Thorpe, Erin, Taylor Williams, Chad Shaw, Evgenii Chekalin, Julia Ortega, Keisha Robinson, Jason Button, et al. 2024. “The Impact of Clinical Genome Sequencing in a Global Population with Suspected Rare Genetic Disease.” American Journal of Human Genetics 111 (7): 1271–81. doi:10.1016/j.ajhg.2024.05.006.